-
Kim YH. Efficacy of acupuncture for treating knee osteoarthritis. Altern Med Alert 2005;8(5):49-53.
-
Kolasinski SL. Magnets for musculoskeletal symptoms. Altern Med Alert 2005;8(5):53-55.
-
Ring M. Mistletoe extract in cancer: An Anthroposophic remedy. Altern Med Alert 2005;8(5):55-60.
-
MyPyramid: The New Look and Message of the USDAs Food Pyramid. Altern Med Alert 2005;8(5):S1-2.
-
As they enter the market, most new medical devices owe their possible success to a convergence of different influential factors. Researchers and developers, investors and government regulators each can make or break a novel product.
-
Rubicon Medical (Salt Lake City) said in mid-April that it had received the CE mark for its Rubicon Filter, an embolic protection system that traps and removes debris that may be dislodged during interventional procedures.
-
Anne Curtis, MD, will be named president of the Heart Rhythm Society (Washington) during Heart Rhythm 2005, the societys 26th annual scientific sessions, this month in New Orleans. Curtis, director of cardiology and CEO of heart services at the University of South Florida (Tampa, Florida), will be the societys third woman president.
-
Reflecting the companys new emphasis on the interventional sector, Abbott Laboratories (Abbott Park, Illinois) last month reported two major forward steps in the product development program of its Abbott Vascular (Redwood City, California) unit. In early April, Abbott Vascular reported that the first patient in the U.S. to be enrolled in its landmark clinical trial to assess the benefits of using stents in the neck arteries of likely stroke patients who have not shown symptoms of the disease was treated at the Hoag Heart and Vascular Institute at Hoag Memorial Hospital Presbyterian (Newport Beach, California).
-
-
The 2005 scientific sessions of the American College of Cardiology (ACC, Bethesda, Maryland), held here in March, highlighted new developments in the rapidly growing areas of drug-eluting stents and implantable cardioverter defibrillators (ICDs), two of the most rapidly growing segments of the interventional cardiology market.
